Cargando…

5-Aminolevulinic Acid Fluorescence-Guided Resection of (18)F-FET-PET Positive Tumor Beyond Gadolinium Enhancing Tumor Improves Survival in Glioblastoma

BACKGROUND: The value of early postoperative (18)F-FET-PET in patients with glioblastoma (GBM) is unclear. Five-aminolevulinic acid (5-ALA) is used for fluorescence-guided resections in these patients and previous data suggest that fluorescence and (18)F-FET-PET both demarcate larger tumor volumes t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Müther, Michael, Koch, Raphael, Weckesser, Matthias, Sporns, Peter, Schwindt, Wolfram, Stummer, Walter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Research—Human—Clinical Studies
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6855932/ https://www.ncbi.nlm.nih.gov/pubmed/31215632 http://dx.doi.org/10.1093/neuros/nyz199

Ejemplares similares

The Value of 5-Aminolevulinic Acid in Low-grade Gliomas and High-grade Gliomas Lacking Glioblastoma Imaging Features: An Analysis Based on Fluorescence, Magnetic Resonance Imaging, (18)F-Fluoroethyl Tyrosine Positron Emission Tomography, and Tumor Molecular Factors
por: Jaber, Mohammed, et al.
Publicado: (2015)

5-Aminolevulinic Acid-derived Tumor Fluorescence: The Diagnostic Accuracy of Visible Fluorescence Qualities as Corroborated by Spectrometry and Histology and Postoperative Imaging
por: Stummer, Walter, et al.
Publicado: (2013)

SURG-08. 5-Aminolevulinic acid (5-ALA)-guided resection of pediatric brain tumors
por: Schwake, Michael, et al.
Publicado: (2022)

HGG-19. 5-AMINOLEVULINIC ACID (5-ALA)-GUIDED RESECTION OF PEDIATRIC BRAIN TUMORS
por: Schwake, Michael, et al.
Publicado: (2021)

Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas
por: Stummer, Walter, et al.
Publicado: (2017)

A Data-Driven Approach to Predicting 5-Aminolevulinic Acid–Induced Fluorescence and World Health Organization Grade in Newly Diagnosed Diffuse Gliomas
por: Müther, Michael, et al.
Publicado: (2022)

Is Visible Aminolevulinic Acid-Induced Fluorescence an Independent Biomarker for Prognosis in Histologically Confirmed (World Health Organization 2016) Low-Grade Gliomas?
por: Jaber, Mohammed, et al.
Publicado: (2019)

Combined intracavitary thermotherapy with iron oxide nanoparticles and radiotherapy as local treatment modality in recurrent glioblastoma patients
por: Grauer, Oliver, et al.
Publicado: (2018)

5-ALA fluorescence in indeterminate grade gliomas
por: Müther, Michael, et al.
Publicado: (2022)

A Pilot Cost-Effectiveness Analysis of Treatments in Newly Diagnosed High-Grade Gliomas: The Example of 5-Aminolevulinic Acid Compared With White-Light Surgery
por: Esteves, Susana, et al.
Publicado: (2015)

The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
por: Poulsen, Sidsel Højklint, et al.
Publicado: (2016)

Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches
por: Holzgreve, Adrien, et al.
Publicado: (2016)

Antitumor Effects of 5-Aminolevulinic Acid on Human Malignant Glioblastoma Cells
por: Jalili-Nik, Mohammad, et al.
Publicado: (2021)

5-Aminolevulinic acid fluorescence-guided endoscopic surgery for intraventricular tumors
por: Takeda, Junichi, et al.
Publicado: (2022)

FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?
por: Carles, Montserrat, et al.
Publicado: (2021)

Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06
por: Barry, Nathaniel, et al.
Publicado: (2023)

Impact of (18)F-FET PET/MRI on Clinical Management of Brain Tumor Patients
por: Brendle, Cornelia, et al.
Publicado: (2022)

Glutaminase 2 expression is associated with regional heterogeneity of 5-aminolevulinic acid fluorescence in glioblastoma
por: Kim, Sojin, et al.
Publicado: (2017)

5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy
por: Howley, Richard, et al.
Publicado: (2023)

Visualizing cellularity and angiogenesis in newly-diagnosed glioblastoma with diffusion and perfusion MRI and FET-PET imaging
por: Liesche-Starnecker, Friederike, et al.
Publicado: (2021)

Editorial: Measuring progression in Multiple Sclerosis: Progressing beyond the ordinary
por: Koch, Carynn, et al.
Publicado: (2022)

Andexanet-Alfa-Associated Heparin Resistance in the Context of Hemorrhagic Stroke
por: Müther, Michael, et al.
Publicado: (2022)

Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout Planning
por: Cao, Fang, et al.
Publicado: (2022)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

[(18)F]FET PET Uptake Indicates High Tumor and Low Necrosis Content in Brain Metastasis
por: Meyer, Hanno S., et al.
Publicado: (2021)

High Interobserver Agreement in the Subjective Classification of 5‐Aminolevulinic Acid Fluorescence Levels in Newly Diagnosed Glioblastomas
por: Mischkulnig, Mario, et al.
Publicado: (2020)

Impact of Levetiracetam Treatment on 5-Aminolevulinic Acid Fluorescence Expression in IDH1 Wild-Type Glioblastoma
por: Wach, Johannes, et al.
Publicado: (2022)

Effect of gadolinium-based nanoparticles on nuclear DNA damage and repair in glioblastoma tumor cells
por: Štefančíková, Lenka, et al.
Publicado: (2016)

Clinically useful tumor fluorescence greater than 24 hours after 5-aminolevulinic acid administration
por: Haider, Sameah, et al.
Publicado: (2022)

5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges
por: Harada, Yoshinori, et al.
Publicado: (2022)

TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic (18)F-FET PET?
por: Unterrainer, Marcus, et al.
Publicado: (2021)

(18)F-FET PET radiomics-based survival prediction in glioblastoma patients receiving radio(chemo)therapy
por: Wiltgen, Tun, et al.
Publicado: (2022)

Orally Administered 5-aminolevulinic Acid for Isolation and Characterization of Circulating Tumor-Derived Extracellular Vesicles in Glioblastoma Patients
por: Maas, Sybren L. N., et al.
Publicado: (2020)

Therapy Defining at Initial Diagnosis of Primary Brain Tumor—The Role of (18)F-FET PET/CT and MRI
por: Nagy, Dávid Gergő, et al.
Publicado: (2023)

Initial Experience of (18) F-FET PET-MR Image Fusion for Evaluation of Recurrent Primary Brain Tumors
por: Dadgar, Habibollah, et al.
Publicado: (2023)

A case of late-onset multiple sclerosis mimicking glioblastoma and displaying intraoperative 5-aminolevulinic acid fluorescence
por: Nestler, U., et al.
Publicado: (2012)

Congruency of tumour volume delineated by FET PET and MRSI
por: Mauler, Jörg, et al.
Publicado: (2015)

5-Aminolevulinic Acid Multispectral Imaging for the Fluorescence-Guided Resection of Brain Tumors: A Prospective Observational Study
por: Charalampaki, Patra, et al.
Publicado: (2020)

Relapse patterns after radiochemotherapy of glioblastoma with FET PET-guided boost irradiation and simulation to optimize radiation target volume
por: Piroth, Marc D., et al.
Publicado: (2016)

A novel SMARCA2-CREM fusion: expanding the molecular spectrum of intracranial mesenchymal tumors beyond the FET genes
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ov75rv1kagfal9uuc360h16i55